Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2010 Mar 24;37(8):1499–1506. doi: 10.1007/s00259-010-1411-7

Table 2.

Radiation dosimetry estimates for 11C-MePPEP and 18F-FMPEP-d2 each from seven healthy subjects

Organ 11C-MePPEP 18F-FMPEP-d2
μGy/MBq μGy/MBq
Mean ± SD Mean ± SD
Adrenals 3.3±0.1 13.3±0.4
Brain 8.0±1.5 26.3±5.4
Breasts 1.8±0.1 7.8±0.4
Gallbladder wall 8.7±3.1 60.7±29.2
LLI wall 2.5±0.1 21.1±1.9
Small intestine 11.6±3.8 38.0±5.5
Stomach 2.5±0.1 11.9±0.5
ULI wall 5.4±1.2 41.4±6.2
Heart wall 7.5±1.2 17.0±1.8
Kidneys 9.9±2.3 28.7±3.8
Liver 16.2±4.2 25.5±5.5
Lungs 11.0±1.7 21.9±8.6
Muscle 2.0±0.1 9.9±0.4
Ovaries 2.8±0.2 16.4±0.9
Pancreas 3.2±0.0 13.6±0.4
Red marrow 4.1±0.2 24.5±5.2
Bone surfaces 4.7±0.4 26.7±3.0
Skin 1.5±0.1 7.2±0.5
Spleen 7.9±2.2 18.3±4.8
Testes 1.6±0.2 9.3±0.7
Thymus 2.1±0.2 9.7±0.5
Thyroid 4.5±1.7 9.3±0.7
Urinary bladder walla 2.0±0.2 66.2±11.4
Uterus 2.6±0.1 17.1±0.7
Effective dose (μSv/MBq) 4.6±0.3 19.7±2.1

LLI lower large intestine, ULI upper large intestine

a

Determined from the dynamic urinary bladder model with a voiding interval of 2.4 h